RxDoctor Payments DataLook up a doctor →

Scott Kim, MD

Interventional Pain Medicine · Greenwood, INNPI 1164650461

Payments from drug & device makers

$17,533in general payments, 2019–2025

Across 792 payments — averaging $22.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • AbbVie$2K
  • ANI Pharmaceuticals, Inc.$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Collegium Pharmaceutical, Inc.$1K
  • Abbott$894
  • plus $8K from 51 others

What the payments were for

  • Travel & lodging$1,2127%
  • Food & beverage$16,30993%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific87$2,591
AbbVie(2 entities)132$2,255
ANI Pharmaceuticals, Inc.52$1,567
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC71$1,174
Collegium Pharmaceutical, Inc.89$1,158
Abbott25$894
Vertos Medical, Inc.11$797
Amgen(2 entities)40$726
Pfizer32$493
Medtronic(2 entities)16$464
Si-bone, Inc.4$372
Scilex Pharmaceuticals Inc.21$343
Biodelivery Sciences International, Inc.17$315
Biohaven Pharmaceuticals, Inc.17$314
Novartis16$280
IBSA Pharma Inc.13$242
Tersera Therapeutics LLC8$239
Teva Pharmaceuticals USA, Inc.10$225
Biotronik NRO, Inc.3$214
Lilly USA, LLC13$205
Pacira Therapeutics, Inc.12$193
Biohaven Pharmaceutical Holding Company Ltd.9$190
Neurocrine Biosciences, Inc.7$187
Lundbeck LLC8$174
Arbor Pharmaceuticals, Inc.7$153
MML US, Inc.4$153
Azurity Pharmaceuticals, Inc.7$135
Stimwave Technologies Incorporated1$120
Impel Pharmaceuticals Inc.5$115
Idorsia Pharmaceuticals US Inc2$114
Redhill Biopharma Inc.6$110
Protega Pharmaceutials Inc2$101
Vertiflex, Inc.1$98
Axsome Therapeutics, Inc.4$97
Almatica Pharma LLC4$75
SPR Therapeutics, Inc1$67
Bioventus LLC4$62
Vertex3$57
Orexo US, Inc.3$47
Valinor Pharma, LLC3$45
Ipsen Biopharmaceuticals, Inc2$44
Ultragenyx Pharmaceutical Inc.2$35
GRT US Holding, Inc.2$34
Johnson & Johnson2$32
Masimo Corporation2$31
Tonix Medicines, Inc.1$27
Averitas Pharma Inc.1$22
Spinal Simplicity, LLC1$21
Relievant Medsystems, Inc.1$18
Painteq LLC1$17
Curonix LLC1$15
Currax Pharmaceuticals LLC1$13
Daiichi Sankyo Inc.1$13
Assertio Therapeutics, Inc.1$13
AstraZeneca1$12
Kowa Pharmaceuticals America, Inc.1$12
Kaleo, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,533 in reported general payments places this provider in the 85th percentile of 68 interventional pain medicine providers in Indiana.

See all interventional pain medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$203,279
Medicare patients
346
Services billed
2,379

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,799$39,906
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen933$20,718
Pregabalin373$9,022
Gabapentin583$7,776
Xtampza ErOxycodone Myristate22$4,806
OxycontinOxycodone Hcl16$4,592
Buprenorphine18$4,275
Oxycodone Hcl208$2,484
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl17$2,084
Tizanidine Hcl108$961
Naloxone Hcl15$791
Morphine Sulfate ErMorphine Sulfate41$767
Cyclobenzaprine Hcl131$705
Celecoxib18$620
Tramadol Hcl99$595

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$1,158$4,80622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 68 interventional pain medicine providers in Indiana.

Other interventional pain medicine in Greenwood

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →